Sleeman, IsobelAspray, TerryLawson, RachaelColeman, ShirleyDuncan, GordonKhoo, Tien KSchoenmakers, InezRochester, LynnBurn, DavidYarnall, Alison2020-05-272020-05-272017-11-01Sleeman, I, Aspray, T, Lawson, R, Coleman, S, Duncan, G, Khoo, T K, Schoenmakers, I, Rochester, L, Burn, D & Yarnall, A 2017, 'The Role of Vitamin D in Disease Progression in Early Parkinson's Disease', Journal of Parkinson's Disease, vol. 7, no. 4, pp. 669-675. https://doi.org/10.3233/JPD-1711221877-7171PubMedCentral: PMC5676984ORCID: /0000-0003-2299-9743/work/168606789https://hdl.handle.net/2164/14379The authors acknowledge the study funders, Parkinson’s UK (J-0802), Newcastle University Lockhart Parkinson’s Disease fund and the Newcastle Biomedical Research Centre. The research was supported by the National Institute of Health Research (NIHR) Newcastle Biomedical Research Unit based at Newcastle upon Tyne Hospitals NHS Foundation Trust/Newcastle University. The research was also supported by NIHR Newcastle CRF Infrastructure funding. Newcastle University acknowledge the support of the NIHR, through the Dementias and Neurodegenerative Diseases Research Network. IS was supported by a NIHR clinical fellowship. The authors would like to thank Sarah Meadows and her colleagues Nutritional Biomarker Analysis laboratory at MRC Elsie Widdowson Laboratory for the analyses of 25 hydroxyvitamin D. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health.7159376engSDG 3 - Good Health and Well-beingbalancecognitiondisease progressionfall25-hydroxy vitamin DParkinson's diseasevitamin DRA0421 Public health. Hygiene. Preventive MedicineParkinson's UKJ-0802National Institute for Health Research (NIHR)Supplementary DataRA0421Journal article10.3233/JPD-17112274